HMGB1 immunostaining was unrelated to parameters of cancer aggressiveness in pancreatic and gastric adenocarcinomas, seminomas, as well as in endometrioid endometrial carcinomas. The gene discussed is HMGB1; the disease is gastric adenocarcinoma.